Found 14 matching trials
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
PHASE3The purpose of this study is to determine whether ozanimod is effective in ...
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
PHASE3This is a study to demonstrate the effect of oral ozanimod as maintenance t...
Location
Holland Center for Family Health
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
PHASE3This is a study to explore the effect of oral ozanimod as an induction trea...
Location
Local Institution - 202
Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate
PHASE1The purpose of this study is to evaluate the effect of ozanimod after repea...
Location
ICON Early Phase Services
A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
PHASE3The purpose of this study is to evaluate the efficacy and safety of ozanimo...
Location
Local Institution - 0012
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
PHASE2This study is a two-part trial consisting of Part A (presented in this reco...
Location
Alta Bates Summit Medical Center
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
PHASE3The purpose of this study is to determine whether RPC1063 is effective in t...
Location
Arizona Digestive Health
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
PHASE3Japanese patients with moderate or severe active ulcerative colitis as a su...
Location
Local Institution - 104
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
PHASE3This is a study to explore the effect of oral ozanimod as an induction trea...
Location
Holland Center for Family Health
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
PHASE3This study is a two-part trial consisting of Part A (see NCT01628393) and P...
Location
Receptos Study Site 115